| __timestamp | Amphastar Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 4167274 |
| Thursday, January 1, 2015 | 174172000 | 5247851 |
| Friday, January 1, 2016 | 150976000 | 4925118 |
| Sunday, January 1, 2017 | 149380000 | 14930297 |
| Monday, January 1, 2018 | 187681000 | 25371768 |
| Tuesday, January 1, 2019 | 190434000 | 23921274 |
| Wednesday, January 1, 2020 | 206506000 | 25338236 |
| Friday, January 1, 2021 | 238029000 | 20182966 |
| Saturday, January 1, 2022 | 250127000 | 17562000 |
| Sunday, January 1, 2023 | 293274000 | 25212000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, Amphastar Pharmaceuticals, Inc. and Pharming Group N.V. have showcased contrasting trends in their cost of revenue. Amphastar's cost of revenue has surged by approximately 84% from 2014 to 2023, reflecting its aggressive expansion and increased production capabilities. In contrast, Pharming Group N.V. has experienced a more modest growth of around 505% in the same period, indicating a steady yet significant scaling of operations.
These insights underscore the diverse strategies employed by these companies in navigating the competitive pharmaceutical landscape.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Viatris Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Cost of Revenue Trends: Catalent, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: Perrigo Company plc vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.